🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Background and purposes:Chloroquine (CLQ), an antimalarial drug, has a lyso...
Status
Terminated
Location
Instituto Nacional de Cancerologia
Start Date
2011-05
Trial ID
NCT01894633
Treatments Being Tested
According to literature reports, about 16.3%-19% of newly diagnosed NSCLC p...
Status
Unknown
Location
Chongqing University Cancer Hospital
Start Date
2021-03-01
Trial ID
NCT04905550
Whole Brain Radiation Therapy (WBRT) has long been the mainstay of treatmen...
Status
Completed
Location
Gamma Knife Center Tilburg, Elisabeth-TweeSteden Hospital
Start Date
2016-02
Trial ID
NCT02953717
Treatments Being Tested
The goal of this Phase I clinical trial is to evaluate how the imaging drug...
Status
Recruiting
Location
Excel Diagnostics & Nuclear Oncology Center
Start Date
2026-08-15
Trial ID
NCT07733674
Treatments Being Tested
This study aims to assess changes in vascular permeability in the brain tum...
Status
Completed
Location
University of Michigan Hospital
Start Date
2005-04
Trial ID
NCT02031237
The Investigators have proposed targeted efforts to address the feasibility...
Status
Not Yet Recruiting
Location
Baylor Scott & White Research Institute
Start Date
2026-08-15
Trial ID
NCT07648901
Treatments Being Tested
RATIONALE: Steroid therapy, such as dexamethasone, may reduce swelling, pai...
Status
Completed
Location
Wansbeck General Hospital
Start Date
2006-10
Trial ID
NCT00403065
Treatments Being Tested
Etoposide-cisplatin/ -carboplatin in combination with PD-L1 inhibitor for 4...
Status
Completed
Location
Hunan cancer hospital
Start Date
2020-06-01
Trial ID
NCT04636762
Treatments Being Tested
This study aims to describe the different treatment time, treatment mode an...
Status
Unknown
Location
Henan cancer hospital
Start Date
2022-05-30
Trial ID
NCT05359120
The incidence of brain metastasis of Her2-negative breast cancer is high, w...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-06-15
Trial ID
NCT06462079
Treatments Being Tested